{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:52:37Z","timestamp":1790146357442,"version":"4.0.1"},"reference-count":55,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":215,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Cancer"],"published-print":{"date-parts":[[2015,8,1]]},"DOI":"10.1002\/ijc.29425","type":"journal-article","created":{"date-parts":[[2015,1,13]],"date-time":"2015-01-13T23:46:40Z","timestamp":1421192800000},"page":"560-570","source":"Crossref","is-referenced-by-count":28,"title":["Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer"],"prefix":"10.1002","volume":"137","author":[{"given":"Samar","family":"Masoumi-Moghaddam","sequence":"first","affiliation":[{"name":"Department of Surgery; St George Hospital, the University of New South Wales; Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Amini","sequence":"additional","affiliation":[{"name":"Department of Surgery; St George Hospital, the University of New South Wales; Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Qun","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery; St. George Hospital, the University of New South Wales; Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Robertson","sequence":"additional","affiliation":[{"name":"Department of Gynaecology Oncology; St George Hospital, the University of New South Wales; Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Surgery; St George Hospital, the University of New South Wales; Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,1,29]]},"reference":[{"key":"10.1002\/ijc.29425-BIB0001|ijc29425-cit-0001","unstructured":"http:\/\/www.aihw.gov.au\/acim-books"},{"key":"10.1002\/ijc.29425-BIB0002|ijc29425-cit-0002","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","article-title":"Ovarian cancer","volume":"4","author":"Cho","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1002\/ijc.29425-BIB0003|ijc29425-cit-0003","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"10.1002\/ijc.29425-BIB0004|ijc29425-cit-0004","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0092-8674(00)80919-8","article-title":"Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the drosophila airways","volume":"92","author":"Hacohen","year":"1998","journal-title":"Cell"},{"key":"10.1002\/ijc.29425-BIB0005|ijc29425-cit-0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10456-008-9089-1","article-title":"Sprouty proteins, masterminds of receptor tyrosine kinase signaling","volume":"11","author":"Cabrita","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1002\/ijc.29425-BIB0006|ijc29425-cit-0006","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2005.12.032","article-title":"Sprouty and cancer: the first terms report","volume":"242","author":"Lo","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1002\/ijc.29425-BIB0007|ijc29425-cit-0007","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10555-014-9497-1","article-title":"The developing story of Sprouty and cancer","volume":"33","author":"Masoumi-Moghaddam","year":"2014","journal-title":"Cancer Metastasis Rev"},{"key":"10.1002\/ijc.29425-BIB0008|ijc29425-cit-0008","first-page":"373826","article-title":"Initial report on differential expression of Sprouty proteins 1 and 2 in human epithelial ovarian cancer cell lines","volume":"2012","author":"Masoumi-Moghaddam","journal-title":"J Oncol 2012"},{"key":"10.1002\/ijc.29425-BIB0009|ijc29425-cit-0009","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1002\/cncr.11345","article-title":"Pathology and classification of ovarian tumors","volume":"97","author":"Chen","year":"2003","journal-title":"Cancer"},{"key":"10.1002\/ijc.29425-BIB0010|ijc29425-cit-0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijgo.2007.11.004","article-title":"History of the FIGO cancer staging system","volume":"101","author":"Odicino","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1002\/ijc.29425-BIB0011|ijc29425-cit-0011","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1158\/0008-5472.CAN-03-3759","article-title":"The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer","volume":"64","author":"Kwabi-Addo","year":"2004","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.29425-BIB0012|ijc29425-cit-0012","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0002-9440(10)63455-4","article-title":"Extra-cellular signal-regulated ERK-1\/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation","volume":"163","author":"Handra-Luca","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1002\/ijc.29425-BIB0013|ijc29425-cit-0013","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.1996.166","article-title":"Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma","volume":"73","author":"Mattern","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1002\/ijc.29425-BIB0014|ijc29425-cit-0014","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2559.1998.00321.x","article-title":"Expression of vascular endothelial growth factor in digestive neuroendocrine tumours","volume":"32","author":"Terris","year":"1998","journal-title":"Histopathology"},{"key":"10.1002\/ijc.29425-BIB0015|ijc29425-cit-0015","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djr393","article-title":"Assessment of Ki67 in breast cancer: recommendations from the international Ki67 in breast cancer working group","volume":"103","author":"Dowsett","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.29425-BIB0016|ijc29425-cit-0016","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1091\/mbc.E05-05-0419","article-title":"Sprouty-2 overexpression in C2C12 cells confers myogenic differentiation properties in the presence of FGF2","volume":"16","author":"Alvaro","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1002\/ijc.29425-BIB0017|ijc29425-cit-0017","doi-asserted-by":"crossref","first-page":"46460","DOI":"10.1074\/jbc.M108234200","article-title":"Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation","volume":"276","author":"Gross","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1002\/ijc.29425-BIB0018|ijc29425-cit-0018","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1083\/jcb.152.5.1087","article-title":"Mammalian Sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells","volume":"152","author":"Impagnatiello","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1002\/ijc.29425-BIB0019|ijc29425-cit-0019","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1158\/1541-7786.MCR-06-0273","article-title":"Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms","volume":"5","author":"Sutterluty","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1002\/ijc.29425-BIB0020|ijc29425-cit-0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.ATV.0000155461.50450.5a","article-title":"Regulation of vascular smooth muscle cell proliferation and migration by human sprouty 2","volume":"25","author":"Zhang","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1002\/ijc.29425-BIB0021|ijc29425-cit-0021","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbrc.2004.08.070","article-title":"Sprouty regulates cell migration by inhibiting the activation of Rac1 GTPase","volume":"323","author":"Poppleton","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/ijc.29425-BIB0022|ijc29425-cit-0022","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1074\/jbc.M006922200","article-title":"Inhibition of angiogenesis by a mouse sprouty protein","volume":"276","author":"Lee","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1002\/ijc.29425-BIB0023|ijc29425-cit-0023","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1158\/1541-7786.MCR-09-0400","article-title":"Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer","volume":"8","author":"Tennis","year":"2010","journal-title":"Mol Cancer Res"},{"key":"10.1002\/ijc.29425-BIB0024|ijc29425-cit-0024","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1042\/BJ20041181","article-title":"Sprouty-4 negatively regulates cell spreading by inhibiting the kinase activity of testicular protein kinase","volume":"387","author":"Tsumura","year":"2005","journal-title":"Biochem J"},{"key":"10.1002\/ijc.29425-BIB0025|ijc29425-cit-0025","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/pros.20353","article-title":"Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer","volume":"66","author":"Wang","year":"2006","journal-title":"Prostate"},{"key":"10.1002\/ijc.29425-BIB0026|ijc29425-cit-0026","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1038\/sj.onc.1207646","article-title":"Overexpression of sprouty 2 inhibits HGF\/SF-mediated cell growth, invasion, migration, and cytokinesis","volume":"23","author":"Lee","year":"2004","journal-title":"Oncogene"},{"key":"10.1002\/ijc.29425-BIB0027|ijc29425-cit-0027","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.febslet.2013.06.040","article-title":"Sprouty2 but not Sprouty4 is a potent inhibitor of cell proliferation and migration of osteosarcoma cells","volume":"587","author":"Rathmanner","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1002\/ijc.29425-BIB0028|ijc29425-cit-0028","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1158\/0008-5472.CAN-05-1072","article-title":"Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma","volume":"66","author":"Fong","year":"2006","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.29425-BIB0029|ijc29425-cit-0029","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/hep.22169","article-title":"Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer","volume":"47","author":"Lee","year":"2008","journal-title":"Hepatology"},{"key":"10.1002\/ijc.29425-BIB0030|ijc29425-cit-0030","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1349-7006.2007.00457.x","article-title":"Sprouty2 regulates growth and differentiation of human neuroblastoma cells through RET tyrosine kinase","volume":"98","author":"Ishida","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1002\/ijc.29425-BIB0031|ijc29425-cit-0031","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1182\/blood-2008-05-156943","article-title":"Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas","volume":"113","author":"Frank","year":"2009","journal-title":"Blood"},{"key":"10.1002\/ijc.29425-BIB0032|ijc29425-cit-0032","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1074\/jbc.M508300200","article-title":"The tumor suppressor PTEN is necessary for human Sprouty 2-mediated inhibition of cell proliferation","volume":"281","author":"Edwin","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1002\/ijc.29425-BIB0033|ijc29425-cit-0033","doi-asserted-by":"crossref","first-page":"22742","DOI":"10.1074\/jbc.M100123200","article-title":"The C terminus of Sprouty is important for modulation of cellular migration and proliferation","volume":"276","author":"Yigzaw","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1002\/ijc.29425-BIB0034|ijc29425-cit-0034","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1074\/jbc.M210359200","article-title":"Protein-tyrosine phosphatase-1B (PTP1B) mediates the anti-migratory actions of Sprouty","volume":"278","author":"Yigzaw","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1002\/ijc.29425-BIB0035|ijc29425-cit-0035","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1158\/0008-5472.CAN-04-1207","article-title":"The ras\/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, Sprouty 1 and Sprouty 2 are deregulated in breast cancer","volume":"64","author":"Lo","year":"2004","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.29425-BIB0036|ijc29425-cit-0036","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/1541-7786.MCR-07-0255","article-title":"Modulation of endocrine pancreas development but not beta-cell carcinogenesis by Sprouty4","volume":"6","author":"Jaggi","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1002\/ijc.29425-BIB0037|ijc29425-cit-0037","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1007\/s13277-013-1587-0","article-title":"Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines","volume":"35","author":"Vanas","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1002\/ijc.29425-BIB0038|ijc29425-cit-0038","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1038\/onc.2010.264","article-title":"Sprouty-2 controls c-met expression and metastatic potential of colon cancer cells: sprouty\/c-met upregulation in human colonic adenocarcinomas","volume":"29","author":"Holgren","year":"2010","journal-title":"Oncogene"},{"key":"10.1002\/ijc.29425-BIB0039|ijc29425-cit-0039","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1074\/jbc.M709046200","article-title":"Evidence that sprouty 2 is necessary for sarcoma formation by H-ras oncogene-transformed human fibroblasts","volume":"283","author":"Lito","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1002\/ijc.29425-BIB0040|ijc29425-cit-0040","first-page":"699","article-title":"Response markers and the molecular mechanisms of action of gleevec in gastrointestinal stromal tumors","volume":"2","author":"Frolov","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/ijc.29425-BIB0041|ijc29425-cit-0041","doi-asserted-by":"crossref","first-page":"e23772","DOI":"10.1371\/journal.pone.0023772","article-title":"Sprouty 2 is an independent prognostic factor in breast cancer and may be useful in stratifying patients for trastuzumab therapy","volume":"6","author":"Faratian","year":"2011","journal-title":"PLoS One"},{"key":"10.1002\/ijc.29425-BIB0042|ijc29425-cit-0042","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1002\/ijc.29425-BIB0043|ijc29425-cit-0043","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jso.22095","article-title":"Differential expression of sprouty genes in hepatocellular carcinoma","volume":"105","author":"Sirivatanauksorn","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1002\/ijc.29425-BIB0044|ijc29425-cit-0044","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1158\/0008-5472.CAN-09-2532","article-title":"Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene","volume":"70","author":"Schaaf","year":"2010","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.29425-BIB0045|ijc29425-cit-0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-003-0797-8","article-title":"Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors","volume":"107","author":"Holtkamp","year":"2004","journal-title":"Acta Neuropathol"},{"key":"10.1002\/ijc.29425-BIB0046|ijc29425-cit-0046","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1038\/onc.2008.129","article-title":"Epigenetic inactivation of the ERK inhibitor Spry2 in B-cell diffuse lymphomas","volume":"27","author":"Sanchez","year":"2008","journal-title":"Oncogene"},{"key":"10.1002\/ijc.29425-BIB0047|ijc29425-cit-0047","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/sj.onc.1208371","article-title":"Epigenetic inactivation of the human Sprouty 2 (hSPRY2) homologue in prostate cancer","volume":"24","author":"McKie","year":"2005","journal-title":"Oncogene"},{"key":"10.1002\/ijc.29425-BIB0048|ijc29425-cit-0048","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.humpath.2010.08.001","article-title":"Promoter hypermethylation and expression of Sprouty 2 in endometrial carcinoma","volume":"42","author":"Velasco","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1002\/ijc.29425-BIB0049|ijc29425-cit-0049","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1158\/0008-5472.CAN-05-1699","article-title":"Gene expression profiling of human sarcomas: insights into sarcoma biology","volume":"65","author":"Baird","year":"2005","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.29425-BIB0050|ijc29425-cit-0050","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1038\/onc.2010.225","article-title":"SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity","volume":"29","author":"Barbachano","year":"2010","journal-title":"Oncogene"},{"key":"10.1002\/ijc.29425-BIB0051|ijc29425-cit-0051","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.ejca.2011.03.029","article-title":"Differential gene expression signatures between colorectal cancers with and without KRAS mutations: crosstalk between the KRAS pathway and other signalling pathways","volume":"47","author":"Watanabe","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1002\/ijc.29425-BIB0052|ijc29425-cit-0052","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/cbt.11.1.13965","article-title":"Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: correlation with the clinical stage of the disease","volume":"11","author":"Feng","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"10.1002\/ijc.29425-BIB0053|ijc29425-cit-0053","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ng.393","article-title":"Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer","volume":"41","author":"Kanetsky","year":"2009","journal-title":"Nat Genet"},{"key":"10.1002\/ijc.29425-BIB0054|ijc29425-cit-0054","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1499-3872(12)60145-3","article-title":"Prognostic significance and clinical relevance of sprouty 2 protein expression in human hepatocellular carcinoma","volume":"11","author":"Song","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1002\/ijc.29425-BIB0055|ijc29425-cit-0055","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/j.1349-7006.2010.01637.x","article-title":"Sprouty2 protein enhances the response to gefitinib through epidermal growth factor receptor in colon cancer cells","volume":"101","author":"Feng","year":"2010","journal-title":"Cancer Sci"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.29425","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.29425","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/ijc.29425\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T16:20:56Z","timestamp":1625156456000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.29425"}},"subtitle":["Spry2 and Spry4 proteins in human epithelial ovarian cancer"],"short-title":[],"issued":{"date-parts":[[2015,1,29]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ijc.29425","archive":["Portico"],"relation":{},"ISSN":["0020-7136"],"issn-type":[{"value":"0020-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,29]]}}}